Monday, December 03, 2007
On December 3, 2007 Palisade Concentrated Equity Partnership II, LP, a $140 million private equity fund managed by Palisade Capital Management, LLC, invested $2.0 million in Mitralign, Inc. ("Mitralign") as part of a $24.0 million Series C financing round. Mitralign has developed an advanced system for treating mitral valve regurgitation, a heart condition which can lead to damage to the heart and other vital organs of the body. Proceeds from the financing round will enable Mitralign to complete its initial clinical experience and to obtain CE Mark approval of the Mitralign System.
View all Latest News & Insight